UCLA Researchers Use Stem Cell Particles to Delay Type 1 Diabetes in Mice
A new study published in Nature Nanotechnology shows that tiny particles released by stem cells can reduce immune attacks on insulin-producing cells and delay diabetes onset in mice. The findings point toward a potential strategy for protecting these critical cells before they're destroyed.
Evidence label explains the kind of source behind this article (for example peer-reviewed literature vs community video). It is not medical advice.
Key takeaways
- Researchers created extracellular vesicles—tiny particles naturally released by stem cells—that helped reduce immune attacks on insulin-producing pancreatic cells in mice
- The approach delayed the onset of type 1 diabetes in the animal model, suggesting a possible way to preserve insulin-producing cells before they're damaged
- The research was inspired by how a mother's immune system naturally tolerates a developing embryo despite genetic differences
- This work remains in early research stages; the findings have not yet been tested in humans
The Problem: Immune Attacks on Insulin-Producing Cells
In type 1 diabetes, the immune system mistakenly attacks insulin-producing cells in the pancreas, gradually destroying the body's ability to regulate blood sugar. While insulin therapy helps manage blood sugar levels, it does not stop the underlying immune attack that damages these critical cells. Finding ways to protect insulin-producing cells before they're destroyed remains an important research goal.
A New Tool: Stem Cell-Derived Particles
UCLA bioengineers investigated whether extracellular vesicles—tiny particles naturally released by nearly all cell types to communicate with one another—could help protect insulin-producing cells. The team focused on vesicles produced by certain stem cells, drawing inspiration from a remarkable biological process: pregnancy.
During pregnancy, a mother's immune system tolerates the developing embryo despite its genetic differences from the father. 'Nature has designed something amazing,' said senior author Song Li, associate dean for graduate and professional education at UCLA. 'If we can better understand how an embryo avoids rejection by the mother's immune system, it could be very useful for a lot of immune-related diseases.'
What the Research Found
In their study, published in Nature Nanotechnology, the UCLA team found that stem cell-derived vesicles helped reduce immune attacks on insulin-producing cells and delayed the onset of diabetes in mice. The results suggest a possible strategy for preserving these cells before they are destroyed, though the work remains in early-stage animal research.
What Comes Next
While these findings are promising, the research has only been tested in mice. Much work remains before this approach could be evaluated in humans. The discovery opens a new avenue for exploring how immune tolerance—a natural process that protects developing embryos—might be harnessed to protect insulin-producing cells in type 1 diabetes.
Evidence label
Origin: uclahealth.org (News report). Evidence: News report — unverified, pending corroboration. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.
Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.
From Type1Cure
Related reading
More evidence-labeled coverage across the Type1Cure library.
- Research summaryCure & AdvancementsCell Replacement Therapy: A New Frontier in Type 1 Diabetes ResearchVideo report, corroborated with 5 indexed studies
- Research summaryCure & AdvancementsWhy Beta Cells Die in Type 1 Diabetes While Alpha Cells SurviveNews report, corroborated with 2 indexed studies
- Research summaryCure & AdvancementsEarly Trial Shows Some People with Type 1 Diabetes Can Reduce or Stop Insulin—Here's What We KnowNews report, corroborated with 3 indexed studies
- Research summaryCure & AdvancementsBeta Cell Therapy: Moving From Lab Promise to Real-World TreatmentVideo report, corroborated with 2 indexed studies
- Research summaryCure & AdvancementsUnderstanding the Eleodon Trial: What Early Results ShowVideo report — unverified, pending corroboration
- Research summaryCure & AdvancementsIslet Cell Therapies Advance: What You Need to KnowNews report, corroborated with 3 indexed studies